News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
26,808 Results
Type
Article (1061)
Press Release (25747)
Section
Business (13090)
Career Advice (70)
Deals (1680)
Drug Delivery (1)
Drug Development (2230)
Employer Resources (2)
FDA (381)
Job Trends (548)
News (16602)
Policy (721)
Tag
Academia (28)
Adcomms (1)
Allergies (7)
Alliances (852)
ALS (2)
Alzheimer's disease (28)
Antibody-drug conjugate (ADC) (3)
Approvals (397)
Artificial intelligence (9)
Autoimmune disease (5)
Bankruptcy (5)
Best Places to Work (493)
BIOSECURE Act (2)
Biosimilars (1)
Bladder cancer (7)
Breast cancer (17)
Cancer (148)
Cardiovascular disease (13)
Career advice (60)
Career pathing (1)
CAR-T (2)
Cell therapy (11)
Cervical cancer (1)
Clinical research (1991)
Collaboration (14)
Compensation (18)
Complete response letters (1)
COVID-19 (28)
CRISPR (3)
C-suite (2)
Cystic fibrosis (3)
Data (276)
Depression (3)
Diabetes (17)
Diagnostics (218)
Digital health (1)
Drug discovery (3)
Drug pricing (1)
Duchenne muscular dystrophy (5)
Earnings (12728)
Editorial (2)
Employer resources (2)
Events (2977)
Executive appointments (5)
FDA (565)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (8)
Gene editing (6)
Generative AI (1)
Gene therapy (9)
GLP-1 (28)
Government (62)
Grass and pollen (1)
Guidances (133)
Healthcare (695)
HIV (2)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (12)
Immuno-oncology (2)
Indications (8)
Infectious disease (35)
Inflammatory bowel disease (7)
Influenza (1)
Intellectual property (20)
Interviews (16)
IPO (1301)
Job creations (82)
Job search strategy (45)
JPM (2)
Kidney cancer (3)
Labor market (4)
Layoffs (6)
Legal (136)
Lung cancer (27)
Lymphoma (15)
Machine learning (1)
Manufacturing (7)
MASH (9)
Medical device (616)
Medtech (619)
Mergers & acquisitions (400)
Metabolic disorders (46)
Multiple sclerosis (18)
Neurodegenerative disease (7)
Neuropsychiatric disorders (2)
Neuroscience (63)
NextGen: Class of 2026 (156)
Non-profit (54)
Obesity (19)
Opinion (5)
Ovarian cancer (3)
Pancreatic cancer (2)
Parkinson's disease (4)
Patents (27)
Patient recruitment (3)
Peanut (3)
People (636)
Pharmacy benefit managers (1)
Phase 1 (450)
Phase 2 (813)
Phase 3 (844)
Pipeline (548)
Policy (3)
Postmarket research (97)
Preclinical (281)
Prostate cancer (19)
Radiopharmaceuticals (9)
Rare diseases (21)
Real estate (107)
Recruiting (2)
Regulatory (584)
Reports (7)
Research institute (38)
Resumes & cover letters (10)
RSV (4)
Schizophrenia (4)
Sickle cell disease (6)
Special edition (1)
Spinal muscular atrophy (4)
Startups (37)
Supply chain (1)
Vaccines (9)
Weight loss (18)
Women's health (5)
Date
Today (5)
Last 7 days (23)
Last 30 days (56)
Last 365 days (1533)
2026 (79)
2025 (1567)
2024 (1805)
2023 (1934)
2022 (2180)
2021 (2109)
2020 (1897)
2019 (1348)
2018 (1073)
2017 (827)
2016 (531)
2015 (814)
2014 (574)
2013 (279)
2012 (398)
2011 (439)
2010 (5915)
Location
Africa (15)
Alabama (2)
Arizona (11)
Asia (1455)
Australia (195)
California (534)
Canada (145)
China (30)
Colorado (28)
Connecticut (24)
Delaware (26)
Europe (3342)
Florida (88)
Georgia (26)
Idaho (1)
Illinois (44)
India (4)
Indiana (36)
Japan (15)
Kansas (4)
Kentucky (2)
Louisiana (8)
Maine (9)
Maryland (74)
Massachusetts (374)
Michigan (16)
Minnesota (26)
Missouri (5)
Montana (2)
Nevada (2)
New Hampshire (9)
New Jersey (169)
New York (181)
North Carolina (89)
Northern California (258)
Ohio (17)
Pennsylvania (121)
South America (38)
Southern California (238)
Tennessee (5)
Texas (69)
United States (2050)
Utah (30)
Virginia (5)
Washington D.C. (3)
Washington State (52)
Wisconsin (6)
26,808 Results for "124".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Formation Bio Licenses miR-124 Activator for Autoimmune Diseases from CTFH
January 30, 2026
·
3 min read
Press Releases
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
January 22, 2026
·
5 min read
Press Releases
SPINEWAY : 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%)
January 14, 2026
·
1 min read
Press Releases
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
December 25, 2025
·
6 min read
Press Releases
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
December 30, 2025
·
5 min read
Press Releases
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer
October 9, 2025
·
6 min read
Press Releases
Vaccines Market Poised for Growth, Expected to Hit USD 124.88 Billion by 2032, says Coherent Market Insights
September 15, 2025
·
1 min read
Press Releases
Cellarity Initiates Phase 1 Clinical Study of CLY-124, a First-in-Class Globin-Switching Oral Medicine for the Treatment of Sickle Cell Disease
June 26, 2025
·
5 min read
Press Releases
Firefly Neuroscience Closes on Financing of up to $12.4 Million
December 31, 2024
·
5 min read
Press Releases
U.S. Biomarkers Market Size Expected to Reach USD 124.49 Billion by 2034
February 18, 2025
·
1 min read
1 of 2,681
Next
